Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 EUR | +2.19% | -1.06% | -10.26% |
Apr. 23 | Maps, to group company project from Novara Health Authority | AN |
Mar. 28 | Futures tentatively up, eyes on macros | AN |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 28.59 | 21.88 | 37.89 | 41.77 | 38.64 | 34.68 | - | - |
Enterprise Value (EV) 1 | 32.99 | 28.89 | 38.98 | 56.65 | 38.64 | 43.31 | 40.58 | 36.65 |
P/E ratio | - | - | - | - | - | 15.9 x | 11.3 x | 9.22 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 1.68 x | 1.22 x | 1.57 x | 1.69 x | 1.4 x | 1.15 x | 1.04 x | 0.95 x |
EV / Revenue | 1.94 x | 1.61 x | 1.61 x | 2.29 x | 1.4 x | 1.43 x | 1.22 x | 1.01 x |
EV / EBITDA | 8.71 x | 8.49 x | 8.11 x | 9.62 x | 7.76 x | 6.5 x | 5.18 x | 4.1 x |
EV / FCF | 58.1 x | -38.7 x | 12.3 x | -9.05 x | 33.7 x | 20.6 x | 14 x | 9.82 x |
FCF Yield | 1.72% | -2.59% | 8.16% | -11% | 2.97% | 4.85% | 7.15% | 10.2% |
Price to Book | - | - | - | - | - | 1.4 x | 1.26 x | 1.12 x |
Nbr of stocks (in thousands) | 9,133 | 9,640 | 9,640 | 11,668 | 12,386 | 12,386 | - | - |
Reference price 2 | 3.130 | 2.270 | 3.930 | 3.580 | 3.120 | 2.800 | 2.800 | 2.800 |
Announcement Date | 3/27/20 | 3/26/21 | 4/11/22 | 3/24/23 | 3/27/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 17.03 | 17.93 | 24.14 | 24.75 | 27.55 | 30.23 | 33.23 | 36.43 |
EBITDA 1 | 3.788 | 3.405 | 4.804 | 5.887 | 4.977 | 6.667 | 7.833 | 8.933 |
EBIT 1 | 2.042 | 1.132 | 2.21 | 3.095 | 4.977 | 3.133 | 4.2 | 5.133 |
Operating Margin | 11.99% | 6.31% | 9.15% | 12.51% | 18.07% | 10.36% | 12.64% | 14.09% |
Earnings before Tax (EBT) 1 | - | - | - | - | 0.9765 | 2.75 | 3.85 | 4.8 |
Net income 1 | - | - | 2.515 | 2.695 | 0.9246 | 2.233 | 3.167 | 3.933 |
Net margin | - | - | 10.42% | 10.89% | 3.36% | 7.39% | 9.53% | 10.8% |
EPS 2 | - | - | - | - | - | 0.1763 | 0.2470 | 0.3037 |
Free Cash Flow 1 | 0.5679 | -0.7471 | 3.179 | -6.258 | 1.147 | 2.1 | 2.9 | 3.733 |
FCF margin | 3.33% | -4.17% | 13.17% | -25.28% | 4.16% | 6.95% | 8.73% | 10.25% |
FCF Conversion (EBITDA) | 14.99% | - | 66.18% | - | 23.04% | 31.5% | 37.02% | 41.79% |
FCF Conversion (Net income) | - | - | 126.41% | - | 124.01% | 94.03% | 91.58% | 94.92% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/27/20 | 3/26/21 | 4/11/22 | 3/24/23 | 3/27/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 4.4 | 7.01 | 1.09 | 14.9 | - | 8.63 | 5.9 | 1.97 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.162 x | 2.058 x | 0.2275 x | 2.527 x | - | 1.295 x | 0.7532 x | 0.2201 x |
Free Cash Flow 1 | 0.57 | -0.75 | 3.18 | -6.26 | 1.15 | 2.1 | 2.9 | 3.73 |
ROE (net income / shareholders' equity) | 28.6% | 9.98% | 17% | 15% | - | 8.8% | 10.9% | 11.8% |
ROA (Net income/ Total Assets) | - | - | 3.39% | 5.43% | - | 5.8% | 7.8% | 9.3% |
Assets 1 | - | - | 74.19 | 49.61 | - | 38.51 | 40.6 | 42.29 |
Book Value Per Share 2 | - | - | - | - | - | 2.000 | 2.220 | 2.500 |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | 2.52 | 5.14 | 5.6 | 7.78 | 4.43 | 2.93 | 3 | 3.1 |
Capex / Sales | 14.81% | 28.67% | 23.2% | 31.42% | 16.08% | 9.7% | 9.03% | 8.51% |
Announcement Date | 3/27/20 | 3/26/21 | 4/11/22 | 3/24/23 | 3/27/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.26% | 37.61M | |
-19.53% | 177B | |
-3.23% | 159B | |
+2.05% | 153B | |
+5.13% | 100B | |
+9.84% | 81.1B | |
+22.85% | 75.87B | |
-8.81% | 69.81B | |
-31.57% | 45.59B | |
-9.69% | 42.96B |
- Stock Market
- Equities
- MAPS Stock
- Financials Maps S.p.A.